The Business Research Company’s report goes into great detail on the alpha mannosidosis market size and growth, alpha mannosidosis market regional analysis, alpha mannosidosis market competitive landscape, and other critical information needed to excel in the alpha mannosidosis industry.

Major players in the alpha mannosidosis market include Chiesi Farmaceutici S.p.A.

TBRC’s comprehensive market report based on extensive research will assist you in seamlessly devising your approaches in order to match key market player strategies.

The alpha mannosidosis market reached a value of nearly $7.60 million in 2020 to $70.06 million in 2025 at a rate of 55.9%. The alpha mannosidosis market is then expected to grow at a CAGR of 15.4% from 2025 and reach $143.14 million in 2030.

North America was the largest region in the alpha mannosidosis market in 2020.

The alpha mannosidosis market consists of sales of therapies for alpha mannosidosis by entities (organizations, sole traders and partnerships) that provide treatment for alpha mannosidosis. Alpha-mannosidosis (a-mannosidosis) is a rare lysosomal storage disorder with an autosomal recessive inheritance caused by mutations in the gene encoding for the lysosomal a-d-mannosidase. Lysosomes are particles bound in membranes within cells that function as the primary digestive units. Key therapies in the treatment of Alpha Mannosidosis include enzyme replacement therapy and bone marrow transplants.

Rising regulatory support for the drug approval of rare diseases in alpha mannosidosis is expected to drive the alpha mannosidosis market in forecast period.

Request a Sample of the Alpha Mannosidosis Market Report

The use of enzyme replacement therapy is increasingly gaining traction in the alpha mannosidosis market. Lamzede (velmanase alfa) is a long-term enzyme replacement therapy in adults, adolescents, and children to help treat mild to moderate forms of alpha-mannosidosis. It is a recombinant human alpha-mannosidase developed as an intravenous enzyme replacement therapy (ERT) to administer the medicine into the bloodstream in order to replace the function of the deficient enzyme in the body. The therapy aims to normalize oligosaccharide levels in the body, which ultimately prevents the progression of the disease and the formation of abnormalities.

TBRC’s Global Alpha Mannosidosis Market Report Is Segmented:
By Therapy Type: Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT)

By Indication: Type I, Type II, Type III

By End User: Hospital, Specialty Clinics

By Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

The Alpha Mannosidosis Market Report 2022 is one of a series of new reports from The Business Research Company that provides an overview of the alpha mannosidosis market globally and regionally, analyzes and forecasts market size, share, alpha mannosidosis market players, alpha mannosidosis market segments, leading competitor revenues, profiles and market shares.

Here Is A List Of Similar Reports From The Business Research Company:

Gene Editing Global Market Report 2022

Cell And Gene Therapy Global Market Report 2022

Hematology Diagnostic Devices And Equipment Global Market Report 2021

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company

Follow us on Twitter: https://twitter.com/tbrc_info

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: